Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 75 results found. Search for [ abbreviated new drug application ]

Results 1 to 21 of 75
BusinessToday.In
June 11, 2018
\"The company has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Bupropion Hydrochloride tablets,\" Alembic Pharmaceuticals said in a BSE filing.


PTI
June 8, 2018



PTI
May 25, 2018



PTI
May 8, 2018



PTI
April 9, 2018



PTI
April 3, 2018



PTI
February 9, 2018



www.businesstoday.in
January 31, 2018



PTI
January 25, 2018



PTI
December 13, 2017



BT Online
November 17, 2017
Giving a thumbs up to the recently introduced Goods and Services Tax (GST), the ratings agency said the reform will promote productivity by removing barriers to interstate trade. The rating agency said that the reforms will improve the business climate in the country and raise productivity.


E Kumar Sharma
New Delhi, November 12, 2017
Every business has the right to adopt legitimate practises to protect their own interest. Right? But a recent article argues that going beyond the patent act, which permits research and development during the life of a patent, some innovator drug companies are busy trying to block this.


P. B. Jayakumar
New Delhi, September 16, 2017
The US-based global CEO of Lupin, Vinita Gupta, tells P.B. Jayakumar about the crises Indian drug companies are facing in the US.


PTI
New Delhi, June 13, 2017
One of the company's wholly owned subsidiaries has received final approval from the USFDA for its abbreviated new drug application (ANDA) for generic version of Zetia, ezetimibe tablets, Sun Pharma said in a BSE filing.


E. Kumar Sharma
New Delhi, June 10, 2017
Dr. Reddy's says it has a plan and a product pipeline to drive growth in spite of regulatory and other challenges. Can it pull it off?


BT Online
New Delhi, April 7, 2017
The S&P BSE Sensex tanked 220.73 points to close at 29,706.61 while the Nifty ended the day 63.65 points to 9,198.30. 


BT Online
New Delhi, April 6, 2017
The S&P BSE Sensex ended the day at 29,927.34, down 46.90 points (0.16%) while the Nifty50 ended the day at 9,261.95, down 3.20 points (0.03%).


BT Online
New Delhi, April 5, 2017
BSE Sensex ended the day 29,974.24, up 64.02 points after touching and intra day high of 30,007, while the NSE Nifty held above its 9,250-mark closing the day at 9,265.15, up 27.30 points.


PTI
New Delhi, December 8, 2016
Drug firm Cipla On Thursday said it has received final approval from the American health regulator to market Entecavir tablets used for treatment of Hepatitis B infection.


BT Online
New Delhi, September 26, 2016
Shares of Marksans Pharma surged over 12 per cent, bucking the negative market trend, after the pharma company received approval from the US health regulator.


PAGES 1 OF 4  1234